Table 2.
The University of Caifornia, Los Angeles, experience with Artemis device, 2009–July 2012
| All biopsy-tracking patients (N = 606) | Tracking and fusion biopsy patients (N = 360) |
|---|---|
| No. of biopsy sessions: 893 | Active surveillance: 188 (52%) |
| No. of biopsy cores: | Previously negative biopsy: 102 (28%) |
| With MRI fusion (360 patients): | First-time biopsy: 70 (20%) |
| Targeted: 1586 (690 targets) | |
| 305 positive (19.2%) | |
| Systematic: 4263 | |
| 374 positive (8.8%) | |
| Without MRI fusion (246 patients): | |
| Systematic: 2952 | |
| Total = 8801 biopsy cores obtained and tracked |
Biopsy procedures begun in September 2009, and fusion biopsies begun in March 2010.